Figure 2

CIAPIN1 and ABCA13 mRNA expression is associated with shorter survival in serous ovarian carcinoma. A: Kaplan-Meier survival curve showing the association between CIAPIN1 mRNA expression in effusions and overall survival (OS) for patients with pre-chemotherapy primary diagnosis effusions (n = 77). Patients with effusions with higher-than-median expression (n = 36, dashed line) had a mean OS of 22 months vs. 40 months for patients whose effusions showed lower-than-median expression (n = 41, solid line; p = 0.007). B: Kaplan-Meier survival curve showing the association between CIAPIN1 mRNA expression in effusions and progression-free survival (PFS) for patients with pre-chemotherapy primary diagnosis effusions (n = 77). Patients with effusions with higher-than-median expression (n = 36, dashed line) had a mean PFS of 7 months vs. 11 months for patients whose effusions showed lower-than-median expression (n = 41, solid line; p = 0.038). C: Kaplan-Meier survival curve showing the association between ABCA13 mRNA expression in effusions and OS for patients with pre-chemotherapy primary diagnosis effusions (n = 77). Patients with effusions with higher-than-median expression (n = 36, dashed line) had a mean OS of 24 months vs. 39 months for patients whose effusions showed lower-than-median expression (n = 41, solid line; p = 0.024).